Notably, we identified Vesicle-associated membrane protein-associated protein A (VAPA) as a key mediator in the transport of IGFBP7 vesicles to lysosomes, facilitating IGFBP7 degradation and thereby attenuating its tumor-suppressive function. The gene discussed is VAPA; the disease is neoplasm.